| Dr David Andrew Reynolds, DO | |
|
3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 | |
| (210) 916-3479 | |
| Not Available |
| Full Name | Dr David Andrew Reynolds |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 13 Years |
| Location | 3551 Roger Brooke Dr, Fort Sam Houston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467748558 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 0102203209 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Hospital | San antonio, TX | Hospital |
| Hill Country Memorial Hospital Inc | Fredericksburg, TX | Hospital |
| Methodist Hospital Stone Oak | San antonio, TX | Hospital |
| Methodist Hospital South | Jourdanton, TX | Hospital |
| Connally Memorial Medical Center | Floresville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Texas Radiology Imaging Centers | 0547153512 | 71 |
| South Texas Radiology Group Pa | 2567365083 | 76 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the introduction of a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique®. Macroplastique is a soft-tissue urethral bulking agent used to treat adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. This permanent, nonresorbable material is injected into the tissues surrounding the urethra to help improve urethral closure to enhance bladder control.
Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.
The World Health Organization (WHO) has published "Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants," a compilation of 10 standards for ethics review of health related research with human participants.
Climate change aggravates global health problems, above all for people in Africa. The group "Climate change and Health in Sub-Saharan Africa" funded by the German Research Foundation studies climate-induced damage to health in Burkina Faso and Kenya.
› Verified 6 days ago
| Entity Name | South Texas Radiology Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851368039 PECOS PAC ID: 2567365083 Enrollment ID: O20040130000694 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the introduction of a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique®. Macroplastique is a soft-tissue urethral bulking agent used to treat adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. This permanent, nonresorbable material is injected into the tissues surrounding the urethra to help improve urethral closure to enhance bladder control.
Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.
The World Health Organization (WHO) has published "Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants," a compilation of 10 standards for ethics review of health related research with human participants.
Climate change aggravates global health problems, above all for people in Africa. The group "Climate change and Health in Sub-Saharan Africa" funded by the German Research Foundation studies climate-induced damage to health in Burkina Faso and Kenya.
› Verified 6 days ago
| Entity Name | South Texas Radiology Imaging Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396718334 PECOS PAC ID: 0547153512 Enrollment ID: O20040204000215 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the introduction of a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique®. Macroplastique is a soft-tissue urethral bulking agent used to treat adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. This permanent, nonresorbable material is injected into the tissues surrounding the urethra to help improve urethral closure to enhance bladder control.
Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.
The World Health Organization (WHO) has published "Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants," a compilation of 10 standards for ethics review of health related research with human participants.
Climate change aggravates global health problems, above all for people in Africa. The group "Climate change and Health in Sub-Saharan Africa" funded by the German Research Foundation studies climate-induced damage to health in Burkina Faso and Kenya.
› Verified 6 days ago
| Entity Name | Singleton Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538107875 PECOS PAC ID: 6305731118 Enrollment ID: O20040315000385 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the introduction of a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique®. Macroplastique is a soft-tissue urethral bulking agent used to treat adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. This permanent, nonresorbable material is injected into the tissues surrounding the urethra to help improve urethral closure to enhance bladder control.
Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.
The World Health Organization (WHO) has published "Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants," a compilation of 10 standards for ethics review of health related research with human participants.
Climate change aggravates global health problems, above all for people in Africa. The group "Climate change and Health in Sub-Saharan Africa" funded by the German Research Foundation studies climate-induced damage to health in Burkina Faso and Kenya.
› Verified 6 days ago
| Entity Name | Community Radiology Associates P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174573273 PECOS PAC ID: 9436132529 Enrollment ID: O20040610000177 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the introduction of a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique®. Macroplastique is a soft-tissue urethral bulking agent used to treat adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. This permanent, nonresorbable material is injected into the tissues surrounding the urethra to help improve urethral closure to enhance bladder control.
Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.
The World Health Organization (WHO) has published "Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants," a compilation of 10 standards for ethics review of health related research with human participants.
Climate change aggravates global health problems, above all for people in Africa. The group "Climate change and Health in Sub-Saharan Africa" funded by the German Research Foundation studies climate-induced damage to health in Burkina Faso and Kenya.
› Verified 6 days ago
| Entity Name | Usa Vein Clinics Of Dallas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205488632 PECOS PAC ID: 2365878295 Enrollment ID: O20200212001015 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the introduction of a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique®. Macroplastique is a soft-tissue urethral bulking agent used to treat adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. This permanent, nonresorbable material is injected into the tissues surrounding the urethra to help improve urethral closure to enhance bladder control.
Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.
The World Health Organization (WHO) has published "Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants," a compilation of 10 standards for ethics review of health related research with human participants.
Climate change aggravates global health problems, above all for people in Africa. The group "Climate change and Health in Sub-Saharan Africa" funded by the German Research Foundation studies climate-induced damage to health in Burkina Faso and Kenya.
› Verified 6 days ago
| Entity Name | Usa Vascular Center Of Dallas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245875061 PECOS PAC ID: 2860822137 Enrollment ID: O20200429000657 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the introduction of a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique®. Macroplastique is a soft-tissue urethral bulking agent used to treat adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. This permanent, nonresorbable material is injected into the tissues surrounding the urethra to help improve urethral closure to enhance bladder control.
Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.
The World Health Organization (WHO) has published "Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants," a compilation of 10 standards for ethics review of health related research with human participants.
Climate change aggravates global health problems, above all for people in Africa. The group "Climate change and Health in Sub-Saharan Africa" funded by the German Research Foundation studies climate-induced damage to health in Burkina Faso and Kenya.
› Verified 6 days ago
| Entity Name | Diagnostic Imaging Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114982808 PECOS PAC ID: 9739087214 Enrollment ID: O20201210001411 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the introduction of a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique®. Macroplastique is a soft-tissue urethral bulking agent used to treat adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. This permanent, nonresorbable material is injected into the tissues surrounding the urethra to help improve urethral closure to enhance bladder control.
Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.
The World Health Organization (WHO) has published "Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants," a compilation of 10 standards for ethics review of health related research with human participants.
Climate change aggravates global health problems, above all for people in Africa. The group "Climate change and Health in Sub-Saharan Africa" funded by the German Research Foundation studies climate-induced damage to health in Burkina Faso and Kenya.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Andrew Reynolds, DO Wramc Bldg 2 Rm 2g01, 2900 Georgia Ave. Nw, Washington, DC 20307-0001 Ph: () - | Dr David Andrew Reynolds, DO 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Ph: (210) 916-3479 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the introduction of a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique®. Macroplastique is a soft-tissue urethral bulking agent used to treat adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. This permanent, nonresorbable material is injected into the tissues surrounding the urethra to help improve urethral closure to enhance bladder control.
Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.
The World Health Organization (WHO) has published "Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants," a compilation of 10 standards for ethics review of health related research with human participants.
Climate change aggravates global health problems, above all for people in Africa. The group "Climate change and Health in Sub-Saharan Africa" funded by the German Research Foundation studies climate-induced damage to health in Burkina Faso and Kenya.
› Verified 6 days ago
Dr. Michael Day Dullea, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 3851 Roger Brooke Dr, Mche-qd (credentials), Fort Sam Houston, TX 78234 Phone: 210-916-5046 | |
Dr. Francis Joseph Cloran, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-4218 | |
Dr. Emilio Fentanes, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-8414 | |
Dr. Jayanta Krishna Chaudhuri, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 | |
Dr. Anthony Wayne Allen, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Brooke Army Medical Center Mche-qd/credentials, Fort Sam Houston, TX 78234 Phone: 210-916-3573 | |
Dr. Aaron Jackson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Bamc- 3851 Roger Brooke Drive, Mche-qd, Fort Sam Houston, TX 78234 Phone: 210-916-2460 | |
Dr. Shane Blake Anderson, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Brooke Army Medical Center, Fort Sam Houston, TX 78234 Phone: 210-916-4062 |